
News|Articles|December 24, 2024
RECAP: 2024 Updates in the GLP-1 Space
Despite the explosion of public interest in these drugs, ongoing shortages and debates over compounding made access difficult.
Advertisement
Advertisement
Advertisement
Advertisement
Trending on Pharmacy Times
1
CKD Outcome Set Elevates Patient-Reported Measures
2
The PBM Reform Clock Is Running to 2028—Here's What Independent Pharmacies Should Do
3
FDA Approves Camizestrant for ESR1-Mutated Breast Cancer
4
Evolocumab Cuts MACE in At-Risk Patients With No Prior Events in VESALIUS-CV
5






































































































